Novel Approaches to Blood Purification

  • E. Behm
  • D. Falkenhagen
  • H. Klinkmann
  • J. M. Courtney
Chapter
Part of the Keynes Seminars book series (KESE)

Abstract

The old idea of the blood purification of a diseased body has acquired a new sense and real possibilities over the last two decades. There are at least two sources for this phenomenon: deeper insights into pathological processes of diseases based on rapid progress in biochemistry, immunology and the genetic sciences, and the development of numerous separation techniques also suitable for blood constituents, particularly for plasma components. A straightforward line can be seen from separation techniques such as plasmapheresis/plasma exchange over cryofiltration, cascade filtration methods and the use of broad-based adsorbents such as charcoal up to the development of selective and specific adsorbents for the binding of only a few components or even one certain plasma constituent. The selective and/or specific removal of pathologically relevant components without any influence on other plasma substances is the aim of a modern plasma treatment therapy. For these purposes, various adsorbents have been developed. Table 1 gives examples of specific immunoadsorbents acting on the principle of the antigen-antibody reaction. (For the research groups see references.) Work in Rostock has involved investigations relating to the development of selective adsorbents. This publication describes aspects of this research.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Behm, E., Kuroda, T., Yamawaki, N., Tsuda, N., Loth, F., Schwachula, G., Sabrowski, E., Falkenhagen, D. and Klinkmann, H. (1987a). In vitro investigations with selective adsorbents for IgE and IgM. Biomaterials, Artificial Cells, and Artificial Organs, 15(1), 101–111.Google Scholar
  2. Behm, E., Toewe, D., Kuroda, T., Yamawaki, N., Tsuda, S., Ernst, B. and Klinkmann, H. (1987b). Binding of lipids by a newly developed synthetic material. 1st Int. Congr. Wld Apheresis Ass., Tokyo, Japan, in press.Google Scholar
  3. Bensinger, W. I., Baker, D. A., Buckner, C. D., Clift, R. A. and Thomas, E. D. (1981). Immunoadsorption for removal of A and B blood-group antibodies. New Engl J. Med., 304, 160–162.CrossRefGoogle Scholar
  4. Björk, L. and Kronvall, G. (1984). Purification and some properties of streptococcal protein G, a novel IgG binding reagent. J. Immun., 133, 969–974.Google Scholar
  5. Borberg, H., Bode, C., Mattele, L., Oette, K., Taucher, M. and Stoffel, W. (1983). LDL-apheresis in hypercholesterolemic patients: technical and clinical aspects, in M. J. Lysaght and H. J. Gurland (eds), Plasma Separation and Plasma Fractionation, Karger, Basel, pp. 266–271.Google Scholar
  6. Forsgren, A., Ghetie, V., Lindmark, R. and Sjöquist, J. (1983). Protein A and its exploitation, in C. S. F. Easmon and C. Adlam (eds), Staphylococci and Staphylococcal Infections 2, Academic Press, London, pp. 429–480.Google Scholar
  7. Kuroda, T., Okamoto, T., Yokoyama, T., Yamawaki, N., Inagaki, K., Umegae, M., Yokoyama, S. and Yamamoto, A. (1987). High capacity adsorbent of low density lipoprotein (LDL) for plasmapheresis. 1st Int. Congr. Wld Apheresis Ass., Tokyo, Japan, in press.Google Scholar
  8. Langone, J. J. (1982). Protein A of Staphylococcus aureus and related immunoglobulin receptors produced by streptococci and pneumococci. Adv. Immun., 32, 157–252.CrossRefGoogle Scholar
  9. Nilsson, I. M., Sundquist, S.-B., Ljung, R., Holmberg, L., Freiburghaus, C. and Björlin, G. (1983). Suppression of secondary antibody response by intravenous immunoglobulin in a patient with haemophilia B and antibodies. Scand. J. Haematol., 30, 458–464.CrossRefGoogle Scholar
  10. Odaka, M., Kobayashi, H., Tabata, Y., Soeda, K., Hayashi, H., Ito, S., Murotani, N., Saito, Y., Nishide, Y., Shinomiya, M. and Yoshida, S. (1987). Long term results of LDL selective plasma adsorption therapy of familial hypercholesterolemia. Biomaterials, Artificial Cells and Artificial Organs, 15(1), 113–124.Google Scholar
  11. Reis, K. J., Ayoub, E. M. and Boyle, M. D. P. (1984a). Streptococcal Fc receptors. I. Isolation and partial characterization of the receptor from a group C streptococcus. J. Immun., 132, 3091–3096.Google Scholar
  12. Reis, K. J., Ayoub, E. M. and Boyle, M. D. P. (1984b). Streptococcal Fc receptors. II. Comparison of the reactivity of a receptor from a group C streptococcus with staphylococcal protein A. J. Immun., 132, 3098–3102.Google Scholar
  13. Sato, T., Nishimiya, J., Arai, K., Anno, M., Yamawaki, N., Kuroda, T. and Inagaki, K. (1983). Selective removal of anti-acetylcholine receptor antibodies in sera from patients with myasthenia gravis in vitro with a new immunoadsorbent, in T. Oda (ed.), Therapeutic Plasmapheresis III, Schattauer Verlag, Stuttgart, pp. 565–568.Google Scholar
  14. Stoffel, W. and Bode, C. (1984). Selective removal of low density lipoproteins, in A. A. Pineda (ed.), Selective Plasma Component Removal, Futura Publ. Co., Mount Kisco, New York, pp. 1–22.Google Scholar
  15. Terman, D. S., Buffaloe, G., Mattioli, C., Cook, G., Tilquist, R., Sullivan, M. and Ayus, J. C. (1979). Extracorporeal immunoadsorption: initial experience in human systemic lupus erythematosus. Lancet, II, 824–827.Google Scholar
  16. Traeger, J., Laville, M., El Habib, R., Moskovtchenko, J. F., Coulet, P. R. and Gautheron, D. C. (1983). Extracorporeal immunoadsorption of DNA-antibodies on DNA-coated collagen films: first results in systemic lupus erythematosus, in Y. Nosé, P. S. Malchesky and J. W. Smith (eds), Plasmapheresis: New Trends in Therapeutic Applications, ISAO Press, Cleveland, OH, pp, 155–166.Google Scholar
  17. Tsuruta, Y., Maeda, K., Shinzato, T., Sezaki, R., Usuda, M., Yamada, K., Obayashi, S., Saito, A., Ohta, K., Yamawaki, N., Kuroda, T. and Inagaki, K. (1983). Clinical application of improved 1–02 immunosorbent column, in Y. Nosé, P. S. Malchesky and J. W. Smith (eds), Plasmapheresis: New Trends in Therapeutic Applications, ISAO Press, Cleveland, OH, pp. 149–154.Google Scholar
  18. Yamazaki, Z., Fujimori, Y., Iizoka, I., Kanai, F., Takahama, T., Wada, T., Asano, K., Yoshizawa, H., Takahashi, Y., Ogita, T., Inoue, N., Yamawaki, N., Inagaki, K. and Tsuda, N. (1984). Immunosorbent plasma perfusion in patients with rheumatoid arthritis or systemic lupus erythematosus. Progr. artif. Organs, No. 204, Vol. 2, 708–712.Google Scholar
  19. Yokoyama, S., Hayashi, R., Kikkawa, T., Tani, N., Takada, S., Hatanaka, K. and Yamamoto, A. (1984). Specific sorbent of apolipoprotein B-containing lipoproteins for plasmapheresis. Arteriosclerosis, 4, 276–282.CrossRefGoogle Scholar
  20. Yokoyama, S., Hayashi, R., Satani, M. and Yamamoto, A. (1985). Selective removal of low density lipoproteins by plasmapheresis in familial hypercholesterolemia. Arteriosclerosis, 5, 613–622.CrossRefGoogle Scholar

Copyright information

© Bioengineering Unit, University of Strathclyde 1988

Authors and Affiliations

  • E. Behm
  • D. Falkenhagen
  • H. Klinkmann
  • J. M. Courtney

There are no affiliations available

Personalised recommendations